TD Private Client Wealth LLC Acquires 501 Shares of Centene Co. (NYSE:CNC)

TD Private Client Wealth LLC boosted its holdings in shares of Centene Co. (NYSE:CNC) by 5.7% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 9,229 shares of the company’s stock after purchasing an additional 501 shares during the quarter. TD Private Client Wealth LLC’s holdings in Centene were worth $695,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in CNC. Fortem Financial Group LLC lifted its holdings in shares of Centene by 35.3% in the third quarter. Fortem Financial Group LLC now owns 8,345 shares of the company’s stock worth $628,000 after buying an additional 2,175 shares in the last quarter. Gould Capital LLC increased its holdings in Centene by 2.7% in the 3rd quarter. Gould Capital LLC now owns 14,400 shares of the company’s stock valued at $1,084,000 after acquiring an additional 372 shares during the last quarter. Vestcor Inc lifted its stake in Centene by 9.3% in the 3rd quarter. Vestcor Inc now owns 13,515 shares of the company’s stock worth $1,017,000 after purchasing an additional 1,150 shares in the last quarter. M&T Bank Corp boosted its holdings in shares of Centene by 6.9% during the 3rd quarter. M&T Bank Corp now owns 30,118 shares of the company’s stock valued at $2,267,000 after purchasing an additional 1,946 shares during the last quarter. Finally, Public Employees Retirement System of Ohio increased its holdings in shares of Centene by 16.1% in the third quarter. Public Employees Retirement System of Ohio now owns 316,798 shares of the company’s stock worth $23,849,000 after purchasing an additional 43,924 shares during the last quarter. 93.63% of the stock is currently owned by institutional investors.

Insider Transactions at Centene

In related news, CFO Andrew Lynn Asher purchased 17,200 shares of Centene stock in a transaction that occurred on Wednesday, November 13th. The shares were bought at an average price of $58.14 per share, with a total value of $1,000,008.00. Following the purchase, the chief financial officer now directly owns 486,847 shares of the company’s stock, valued at approximately $28,305,284.58. This represents a 3.66 % increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Sarah London acquired 4,117 shares of the stock in a transaction on Friday, November 8th. The stock was bought at an average cost of $60.80 per share, with a total value of $250,313.60. Following the completion of the transaction, the chief executive officer now owns 667,229 shares in the company, valued at $40,567,523.20. This trade represents a 0.62 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Company insiders own 0.33% of the company’s stock.

Centene Stock Up 2.4 %

Shares of NYSE CNC opened at $59.41 on Friday. Centene Co. has a 1 year low of $55.03 and a 1 year high of $81.42. The firm has a 50-day simple moving average of $62.02 and a two-hundred day simple moving average of $68.62. The company has a market cap of $29.99 billion, a P/E ratio of 10.31, a PEG ratio of 0.78 and a beta of 0.46. The company has a debt-to-equity ratio of 0.64, a current ratio of 1.10 and a quick ratio of 1.10.

Analysts Set New Price Targets

A number of equities analysts recently commented on the company. Oppenheimer dropped their price target on Centene from $95.00 to $85.00 and set an “outperform” rating for the company in a research note on Friday. UBS Group upgraded shares of Centene from a “neutral” rating to a “buy” rating and boosted their price target for the stock from $79.00 to $80.00 in a research report on Friday. Jefferies Financial Group lowered shares of Centene from a “hold” rating to an “underperform” rating and lowered their price objective for the company from $68.00 to $52.00 in a research report on Tuesday. Barclays boosted their target price on shares of Centene from $91.00 to $93.00 and gave the stock an “overweight” rating in a report on Friday. Finally, Sanford C. Bernstein lowered their price target on shares of Centene from $96.00 to $88.00 and set an “outperform” rating for the company in a report on Wednesday, October 30th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and nine have issued a buy rating to the stock. Based on data from MarketBeat, Centene presently has an average rating of “Moderate Buy” and an average target price of $81.31.

Centene Company Profile

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.